ArticleEuropean radiology2026
Quantitative analysis of enhanced CT in predicting microvascular invasion and pathological grading of hepatocellular carcinoma.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A study on screening of postoperative chemotherapy beneficial populations in stage II colorectal cancer based on diffusion weighted imaging andJournal of gastrointestinal oncology · 2026Article
- A reproducible ultrasound localization microscopy framework for the quantitative imaging of hepatocellular carcinoma on a clinical ultrasound system.Theranostics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveTo develop and evaluate nomograms incorporating clinical features and quantitative CT parameters for the preoperative prediction of microvascular invasion (MVI) and pathological grading in patients with hepatocellular carcinoma (HCC). MATERIALS AND
methodsThis retrospective multicenter study involved 684 consecutive patients with pathologically confirmed HCC. In this context, 553 patients from Center 1 were randomly split into training (70%) and internal validation (30%) cohorts, and 131 patients from Center 2 served as an external validation cohort. Predictive factors for MVI-positive and high-grade HCC were identified through univariate and multivariate logistic regression. Two nomograms combining clinical factors and CT quantitative parameters were developed.
resultsFor MVI prediction, multivariate analysis identified HBV infection, an AFP concentration > 20 ng/mL, a larger tumor diameter, a higher arterial absolute enhancement value (AAEV), and a lower portal relative enhancement ratio (PRER) as independent predictors. The nomogram achieved area under the curve (AUC) values of 0.769 (95% CI: 0.720-0.818), 0.771 (0.692-0.850), and 0.760 (0.648-0.872) in the training, internal validation, and external validation cohorts, respectively. For pathological grade prediction, younger age, an AFP concentration > 20 ng/mL, a larger tumor diameter, and a lower PRER were independent predictors. The corresponding nomograms had AUCs of 0.696 (0.639-0.752), 0.644 (0.547-0.741), and 0.768 (0.681-0.856) across cohorts. Both nomograms demonstrated excellent calibration and significant clinical utility for decision curve analysis.
conclusionNomograms integrating clinical features and quantitative CT parameters facilitate accurate preoperative prediction of MVI status and pathological grading in HCC patients, demonstrating strong potential for clinical implementation. KEY POINTS: Question Predicting microvascular invasion (MVI) and pathological grading preoperatively in hepatocellular carcinoma (HCC) patients using a clinically practical and cost-effective method remains challenging. Findings Quantitative parameters derived from contrast-enhanced CT demonstrated the ability to predict MVI and pathological grade, with validated models demonstrating robust diagnostic performance and clinical applicability. Clinical relevance Nomograms, which integrate clinical features and quantitative CT parameters, represent a clinically applicable tool for the preoperative prediction of MVI status and pathological grading in HCC patients, facilitating personalized treatment planning and optimized patient management.
Indexed as
Identifiers
41171351What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.